During trading today, both the Healthcare sector (XLV) and the S&P500 showed little movement.
The ETF has moved down across its 50-day moving average of $36.78 today. While being down today, the ETF, as a proxy for sector performance, tracked closer to the overall market today than over the past month. Entering today's trading, XLV was up 0.4% over the last thirty trading days while the S&P 500 was down 1.2%.
Halozyme Therapeutics, Inc. (HALO) was a major loser in the sector. Its price dropped 12.5% (-$1.52) to close at $10.63, as 3.8 million shares moved. The stock traded between $10.48 and $11.77. Shares are down $2.37 (-18.2%) from a price of $13 on April 2, 2012.
Increasing 11.3% (+$1.25) to close at $12.34, ChemoCentryx, Inc. (CCXI) was a major gainer in the sector. Today, 31,574 shares traded hands. The stock traded in a range of $10.97 to $13.48.
MBLX rose 9.4% to close at $3.04, crossing its 50-day moving average of $2.96. Meanwhile, Optimer Pharmaceuticals, Inc. (OPTR) dropped 10% to close at $12.35, moving below its 200-day moving average or $12.68.
pSivida Corp. (PSDV) rose 3.2% to close at $1.62, approaching its 50-day moving average of $1.73. It has also moved closer to its 200-day moving average of $2.16. Medivation, Inc. (MDVN) fell 4.8% to close at $74.09, moving closer to its 50-day moving average of $72.02. Also, the stock moved closer to its 200-day moving average of $34.75.